Fujifilm outlays whopping $850M for its Diosynth CMDO wing, looking to rapidly scale cell culture production
Fujifilm Diosynth Biotechnologies is on a spending spree and not stopping yet.
The Japanese firm is adding manufacturing capability at its core CDMO wing by …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.